Assetmark Inc. Raises Stock Holdings in CME Group Inc. (NASDAQ:CME)

Assetmark Inc. grew its holdings in shares of CME Group Inc. (NASDAQ:CME) by 5.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,125 shares of the financial services provider’s stock after buying an additional 1,249 shares during the quarter. Assetmark Inc.’s holdings in CME Group were worth $5,323,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in CME. Wealth Enhancement Advisory Services LLC increased its position in shares of CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after purchasing an additional 8,443 shares during the last quarter. Cetera Investment Advisers increased its holdings in CME Group by 429.1% in the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares during the last quarter. Brookstone Capital Management raised its stake in CME Group by 12.2% during the second quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock valued at $6,156,000 after buying an additional 3,325 shares in the last quarter. TD Asset Management Inc lifted its holdings in CME Group by 16.1% during the 1st quarter. TD Asset Management Inc now owns 371,849 shares of the financial services provider’s stock worth $80,055,000 after buying an additional 51,689 shares during the last quarter. Finally, Epoch Investment Partners Inc. grew its position in shares of CME Group by 4.7% in the 1st quarter. Epoch Investment Partners Inc. now owns 99,947 shares of the financial services provider’s stock worth $21,518,000 after acquiring an additional 4,454 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CME shares. Barclays raised their price objective on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. The Goldman Sachs Group boosted their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Morgan Stanley raised their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Keefe, Bruyette & Woods upped their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Finally, Oppenheimer raised their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $224.47.

CME Group Trading Up 0.1 %

NASDAQ:CME opened at $225.93 on Tuesday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36. The business has a fifty day moving average of $221.72 and a 200-day moving average of $209.84. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $81.36 billion, a price-to-earnings ratio of 23.80, a PEG ratio of 5.68 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company earned $2.25 EPS. Equities analysts predict that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is currently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.